關鍵數據
11.420今開
11.990最高
2.64K成交量
0.00本益比TTM
虧損本益比動
--股利TTM
0.01%換手率
11.190昨收
10.555最低
28.87K成交額
0.00本益比靜
2.40市淨率
0.00%股息率 TTM
--ROA
15.29052週最高
0.11量比
--淨利潤
33.29M總股本
--每股盈餘TTM
--Beta
--ROE
8.03052週最低
12.82%振幅
82.97%毛利率
379.84M總市值
-0.38回報/風險
4.79%風險率

即將為您帶來更多新聞,敬請期待。 。 。
分析師評級
強力買入評級
18.000目標均價
+70.13%漲幅空間
MOBI.NB 最新財報電話會記錄
Mobia Medical (MOBI) 2026年第3季法說會:營收成長 73%,調升財測指引
Mobia Medical (MOBI) 2026 年第三季營收成長 73% 至 1,560 萬美元,毛利率達 83.2%,並調升全年營收財測指引。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
MOBI.NB 簡介
Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System includes an implantable device that stimulates the vagus nerve only when intentionally activated, triggering the release of neuromodulators, including acetylcholine, norepinephrine, and serotonin. Its neuromodulators create a heightened state of plasticity in the brain, such that neural networks can more readily adapt and reform in response to stimuli. The implantable components of the Vivistim System-namely, the implantable pulse generator (IPG) and lead-are implanted through a minimally invasive outpatient procedure that takes approximately 60 minutes.
行業醫療設備與耗材
公司代碼MOBI
員工數量0
國家United States of America
常見問題
MOBI.NB(MOBI)的當前股價是 11.19。
現在MOBI.NB(MOBI)的股票是買入、持有還是賣出?
根據分析師評級,MOBI.NB(MOBI)的總體評級為STRONG BUY,目標價格為18.00。